CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Flow cytometryWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)

Name (Synonyms) Correlation
drug1853 Placebo oral tablet Wiki 0.19
drug262 Azithromycin Wiki 0.17
drug1086 Hydroxychloroquine Wiki 0.10

Correlated MeSH Terms (5)

Name (Synonyms) Correlation
D014777 Virus Diseases NIH 0.12
D003141 Communicable Diseases NIH 0.09
D007239 Infection NIH 0.06
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Functional Exhaustion of T Cells in COVID19 Patients

The primary end-point of our prospective, observational study is to count T cells in patients with laboratory-confirmed COVID-19 and healthy controls. In addition, the expression of T cell exhaustion marker was measured in COVID-19 cases.

NCT04470323 T Cell Deficiency Diagnostic Test: Flow cytometry

Primary Outcomes

Description: Detection of the percentage of CD4+ (T-helper cells) in COVID 19 patients and healthy volunteers.

Measure: CD4+ (T-helper cells) in COVID 19 patients and healthy volunteers.

Time: Baseline

Description: Detection of the percentage of CD8+ (T-cytotoxic cells) in COVID 19 patients and healthy volunteers .

Measure: CD8+ (T-cytotoxic cells) in COVID 19 patients and healthy volunteers.

Time: Baseline

Description: Detection of the percentage of expression of PD-1 on CD8+ and CD4+ cells in COVID 19 patient and healthy volunteers.

Measure: Detect PD-1 on CD8+ and CD4+ cells in COVID 19 patients and healthy volunteers .

Time: Baseline

Description: Detection of the frequency of CD28+ and CD3+ cells in COVID 19 patients and healthy volunteers .

Measure: Detect CD28+ and CD3+ cells in COVID 19 patients and healthy volunteers.

Time: Baseline

No related HPO nodes (Using clinical trials)